GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

The Mounjaro (tirzepatide) product information warns that inflammation of the pancreas (acute pancreatitis) is an uncommon ...

The UK is investigating a rise in acute pancreatitis cases linked to GLP-1 weight-loss drugs, exploring possible genetic ...

The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...

Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, ...

They go by various names but the injections work by curbing appetite, lowering blood sugar and slowing food digestion.

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...